Eotaxin-3, an eosinophil chemoattractant [87–89], has been found to be elevated in conditions characterized by type 2 inflammation such as asthma [90], atopic dermatitis [91], and eosinophilic esophagitis [92, 93]. This evidence concerns the gene CCL26 and atopic eczema.